mgiuliani

Johnson & Johnson (JNJ)

Long
NYSE:JNJ   Johnson & Johnson
9
The acquisition of Actelion for 30 mld dollars is a good strike, the EPS for the 2017 are at 6.60 dollars (1.65 dollars for quarter), this equity has a good yield and bright dividend growth prospects. In our view we think that it is a buy stock, with an interesting dividend yeld of 2.85%

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.